Coordinatore | Only For Children Pharmaceuticals
Organization address
address: Rue Henri Barbusse 35 bis contact info |
Nazionalità Coordinatore | France [FR] |
Totale costo | 4˙244˙817 € |
EC contributo | 3˙316˙415 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2007-B |
Funding Scheme | CP-FP |
Anno di inizio | 2008 |
Periodo (anno-mese-giorno) | 2008-11-01 - 2012-04-30 |
# | ||||
---|---|---|---|---|
1 |
Only For Children Pharmaceuticals
Organization address
address: Rue Henri Barbusse 35 bis contact info |
FR (Paris) | coordinator | 1˙440˙678.80 |
2 |
VENN LIFE SCIENCES (FRANCE)
Organization address
city: Paris contact info |
FR (Paris) | participant | 535˙530.00 |
3 | Laboratoire Philippe Davioud | FR | participant | 308˙499.60 |
4 |
REGION HOVEDSTADEN
Organization address
address: KONGENS VAENGE 2 contact info |
DK (HILLEROD) | participant | 259˙941.60 |
5 |
FRANCE EUROPE INNOVATION
Organization address
address: RUE DES RENAUDES 32 contact info |
FR (PARIS) | participant | 186˙091.20 |
6 |
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
Organization address
address: 3 Avenue Victoria contact info |
FR (PARIS) | participant | 185˙214.00 |
7 |
HEINRICH-HEINE-UNIVERSITAET DUESSELDORF
Organization address
address: UNIVERSITAETSSTRASSE 1 contact info |
DE (DUSSELDORF) | participant | 110˙400.00 |
8 |
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL
Organization address
address: OLSHAUSENSTRASSE 40 contact info |
DE (KIEL) | participant | 72˙000.00 |
9 |
PharmaFlow Ltd
Organization address
address: Lisbunny Industrial Estate contact info |
IE (Co Tipperary) | participant | 69˙873.50 |
10 |
HOSPICES CIVILS DE LYON
Organization address
address: 3 Quai des Celestins contact info |
FR (LYON) | participant | 54˙000.00 |
11 |
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE
Organization address
address: AVENUE OSCAR LAMBRET 2 contact info |
FR (LILLE) | participant | 47˙895.40 |
12 |
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
Organization address
address: Allee de l'Ile Gloriette 5 contact info |
FR (NANTES) | participant | 46˙291.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Only for Children Pharmaceuticals, a French based Small and Medium-sized Enterprise (SME) developing drug for children, is the Coordinator of a multinational, multidisciplinary and complementary Consortium. This Consortium is composed of highly qualified organizations and notorious clinicians in pediatric hemato-oncology. The Consortium is an integrated team of competencies (clinicians, pædiatricians, pharmacokineticists, pharmacists, manufacturers, engineers, regulatory and ethical experts) capable of executing a pædiatric drug development from its designing to market. The Consortium will perform the non-clinical development of Methotrexate (MTX) and the non-clinical and clinical development of 6-Mercaptopurine (6MP) oral liquid formulations adapted for maintenance treatment of pediatric acute lymphoblastic leukemia with the crucial objective to make available these adapted formulation by 2012 at the latest. Methotrexate and 6-mercaptopurine are on the EMEA Priority list of off-patent medicinal products of paediatric working party of the European medicine agency - June 2007. On September 2007, EMEA’s COMP Committee has granted the orphan status to Methotrexate (oral liquid) and 6-mercaptopurine (oral liquid).'
Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure
Read MoreOptimization of stem cell therapy for clinical trials of degenerative skin and muscle diseases
Read MoreOrphans Unite: chILD better together – European Management Platform for Childhood Interstitial Lung Diseases
Read More